FDA News

 

Generic Nizatidine Antacid Wins Approval for Amneal

Amneal Pharmaceuticals has received FDA approval to market the first generic nizatidine oral solution to treat heartburn, gastroesophageal reflux disease and conditions associated with excess acid secretion.


300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.